GlassScriptPhysician profile
Michael G Swiatek
NPI 1275782377
$1,542.81
in general payments reported to CMS, 2019-2025
16 companies · $227 in 2025
The $227 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $916 · 2020: $76.63 · 2021: $66.99 · 2022: $74.40 · 2023: $49.87 · 2024: $132 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $408.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $916.20 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $155.15 | 2024-2025 | Austedo Xr, Ajovy |
| Ani Pharmaceuticals, INC. | $85.75 | 2024-2025 | Purified Cortrophin Gel |
| Novartis Pharmaceuticals Corporation | $68.50 | 2023-2025 | |
| Smith+Nephew, INC. | $60.12 | 2020-2022 | |
| Wright Medical Technology, INC. | $45.50 | 2020 | |
| Paratek Pharmaceuticals, INC. | $32.03 | 2022-2023 | Nuzyra |
| Organogenesis INC. | $26.47 | 2021 | |
| Lilly USA, LLC | $24.66 | 2024 | Emgality, Reyvow |
| Amgen INC. | $24.62 | 2021 | |
| Biotissue Holdings INC. | $24.30 | 2024 | |
| Zyla Life Sciences, INC. | $19.60 | 2020 | |
| Abbvie INC. | $18.07 | 2024 | |
| Bioventus LLC | $15.90 | 2021 | |
| Alexion Pharmaceuticals, INC. | $13.08 | 2023 | Ultomiris |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $12.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Swiatek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.